BioWorld

April 5, 2010

View Archived Issues

Sequencing Speeds Up, But Drug Discovery Still a Slog

Read More

Biotech's Future: BioWorld Gives You 2020 Vision in 2010!

Read More

Appointments And Advancements

Read More

Vital Signs

Read More

Other News To Note

Read More

Financings Roundup

Read More

Clinic Roundup

Read More

Bench Press

Read More

Salix Liver-Failure Win Puts Spotlight on Xifaxan in IBS

Salix Pharmaceuticals Inc.'s path forward should become clear shortly with the approved antibiotic Xifaxan in its third potential, and much-coveted, indication: irritable bowel syndrome. (BioWorld Today) Read More

New NYU Stem Cell Lines Boost NIH Registry to 51

Read More